19 results
8-K
EX-99.1
TLIS
Talis Biomedical Corp
27 Jul 23
Regulation FD Disclosure
8:30am
panels. Results from these studies, presented in poster sessions at the 2023 IDSOG Annual Meeting in Denver, Colorado, support Talis Biomedical’s mission
8-K
EX-99.1
TLIS
Talis Biomedical Corp
23 May 23
Departure of Directors or Certain Officers
8:15am
and value creation. I welcome Heiner to Talis Bio and look forward to working with the board and the executive leadership team to deliver on our mission
8-K
EX-99.2
fbg56f3po2luh9
15 Nov 21
Talis Biomedical Announces Third Quarter 2021 Financial Results and Business Progress
4:21pm
10-Q
aiwogwamtf051
13 May 21
Quarterly report
4:23pm
10-K
sb0w5
30 Mar 21
Annual report
5:22pm
424B4
igwyhqj1
12 Feb 21
Prospectus supplement with pricing info
4:31pm
S-1/A
EX-10.15
c4qnau
8 Feb 21
IPO registration (amended)
8:27am
S-1/A
ta39yz
8 Feb 21
IPO registration (amended)
8:27am
S-1
frev8kwtri8b
22 Jan 21
IPO registration
5:18pm
DRS/A
8txbtpq
6 Jan 21
Draft registration statement (amended)
12:00am
DRS
j40vo8zb
15 Oct 20
Draft registration statement
12:00am
- Prev
- 1
- Next